Capricor Therapeutics Inc (CAPR.OQ)
CAPR.OQ on NASDAQ Stock Exchange Capital Market
1.16USD
17 Sep 2018
1.16USD
17 Sep 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$1.16
$1.16
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
25,930
25,930
52-wk High
$4.25
$4.25
52-wk Low
$0.98
$0.98
About
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing regenerative medicine and large molecule products for the treatment of disease, with a primary focus on the... (more)
Overall
| Beta: | -2.65 |
| Market Cap(Mil.): | $67.20 |
| Shares Outstanding(Mil.): | 23.50 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CAPR.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 85.68 | 32.76 |
| EPS (TTM): | -0.83 | -- | -- |
| ROI: | -645.84 | 1.78 | 14.61 |
| ROE: | -- | 3.29 | 16.33 |
Competitors
| Price | Chg | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $140.54 | +0.58 |
| Novartis AG (NOVN.S) | CHF81.46 | -0.38 |
| Merck & Co., Inc. (MRK.N) | $70.42 | 0.00 |
| Bayer AG (BAYGn.DE) | €73.30 | +0.40 |
| Bayer AG (BAYE.F) | -- | -- |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 8,661.00 | -66.00 |
| Zealand Pharma Aktieselskabet (ZELA.CO) | kr.118.00 | +3.80 |
| Palatin Technologies, Inc. (PTN.A) | $1.04 | -0.01 |
Estimates